Sucampo Pharmaceuticals, Inc. 4
4 · Sucampo Pharmaceuticals, Inc. · Filed Aug 31, 2015
Insider Transaction Report
Form 4
Getman Daniel P
Director
Transactions
- Sale
Class A Common Stock
2015-08-28$28.14/sh−30,000$844,200→ 0 total - Exercise/Conversion
Class A Common Stock
2015-08-28$3.20/sh+30,000$96,000→ 30,000 total - Exercise/Conversion
Director Stock Option (right to buy)
2011-09-01−30,000→ 80,000 totalExercise: $3.20Exp: 2021-09-01→ Class A Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.865 to $28.49, inclusive. The reporting person undertakes to provide Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]Vesting commenced on December 1, 2011 in 12 equal quarterly installments.